Literature DB >> 18493880

Mesenchymal stem cells in cancer.

John Stagg1.   

Abstract

It is becoming increasingly evident that stromal cells such as macrophages, mast cells, adipocytes and mesenchymal cells associated with tumors significantly contribute to tumorigenesis. Some types of cancer indeed profoundly rely on extrinsic signals afforded by infiltrating or neighbouring cells for survival, proliferation and dissemination. Tissue disruption that results from tumor growth further activates tissue repair and inflammatory reactions that significantly shape the nature of the developing tumors. Over the past recent years, several studies have revealed that mesenchymal stem cells (MSCs) are recruited to tumors and play a particularly important role in the regulation of both solid and haematological malignancies. The tumor-homing properties of MSCs have further led to studies investigating their therapeutic use as targeted delivery vehicles of gene products. I hereafter discuss the role of MSCs in cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18493880     DOI: 10.1007/s12015-008-9030-4

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  43 in total

1.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Authors:  Massimiliano Gnecchi; Huamei He; Olin D Liang; Luis G Melo; Fulvio Morello; Hui Mu; Nicolas Noiseux; Lunan Zhang; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

2.  A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.

Authors:  William G Gunn; Adam Conley; Lisa Deininger; Scott D Olson; Darwin J Prockop; Carl A Gregory
Journal:  Stem Cells       Date:  2005-11-17       Impact factor: 6.277

3.  Transforming growth factor-beta signaling in stem cells and cancer.

Authors:  Lopa Mishra; Rik Derynck; Bibhuti Mishra
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

4.  In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment.

Authors:  C H Kim; H E Broxmeyer
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition.

Authors:  Daniel Rubio; Silvia Garcia; Teresa De la Cueva; Ma F Paz; Alison C Lloyd; Antonio Bernad; Javier Garcia-Castro
Journal:  Exp Cell Res       Date:  2007-11-29       Impact factor: 3.905

6.  CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells.

Authors:  Linhua Jin; Yoko Tabe; Sergej Konoplev; Yuanyuan Xu; Clinton E Leysath; Hongbo Lu; Shinya Kimura; Akimichi Ohsaka; Mary-Beth Rios; Leslie Calvert; Hagop Kantarjian; Michael Andreeff; Marina Konopleva
Journal:  Mol Cancer Ther       Date:  2008-01       Impact factor: 6.261

7.  Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

Authors:  Mingfang Ao; Omar E Franco; Dean Park; Dayanidhi Raman; Karin Williams; Simon W Hayward
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

Authors:  R M Dwyer; S M Potter-Beirne; K A Harrington; A J Lowery; E Hennessy; J M Murphy; F P Barry; T O'Brien; M J Kerin
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

9.  Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

Authors:  Maria Ester Bernardo; Nadia Zaffaroni; Francesca Novara; Angela Maria Cometa; Maria Antonietta Avanzini; Antonia Moretta; Daniela Montagna; Rita Maccario; Raffaella Villa; Maria Grazia Daidone; Orsetta Zuffardi; Franco Locatelli
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

10.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma.

Authors:  Aarif Y Khakoo; Shibani Pati; Stasia A Anderson; William Reid; Mohamed F Elshal; Ilsa I Rovira; Ahn T Nguyen; Daniela Malide; Christian A Combs; Gentzon Hall; Jianhu Zhang; Mark Raffeld; Terry B Rogers; William Stetler-Stevenson; Joseph A Frank; Marvin Reitz; Toren Finkel
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

View more
  47 in total

Review 1.  Modeling sarcomagenesis using multipotent mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Pablo Menendez
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

2.  Effects of photodynamic treatment on mesenchymal stromal cells.

Authors:  O O Udartseva; E R Andreeva; L B Buravkova
Journal:  Dokl Biol Sci       Date:  2013-07-03

Review 3.  Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde?

Authors:  Rebecca S Y Wong; Soon-Keng Cheong
Journal:  Clin Exp Med       Date:  2013-06-23       Impact factor: 3.984

Review 4.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

Review 5.  Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cells.

Authors:  Muriel Mathonnet; Aurelie Perraud; Niki Christou; Hussein Akil; Carole Melin; Serge Battu; Marie-Odile Jauberteau; Yves Denizot
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.

Authors:  Karen McLean; Yusong Gong; Yunjung Choi; Ning Deng; Kun Yang; Shoumei Bai; Lourdes Cabrera; Evan Keller; Laurie McCauley; Kathleen R Cho; Ronald J Buckanovich
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

7.  Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis.

Authors:  Suk Ho Bhang; Seahyoung Lee; Jung-Youn Shin; Tae-Jin Lee; Hyeon-Ki Jang; Byung-Soo Kim
Journal:  Mol Ther       Date:  2013-01-13       Impact factor: 11.454

Review 8.  Chemotherapy-induced metastasis: mechanisms and translational opportunities.

Authors:  George S Karagiannis; John S Condeelis; Maja H Oktay
Journal:  Clin Exp Metastasis       Date:  2018-01-06       Impact factor: 5.150

9.  Tumor cell behaviour modulation by mesenchymal stromal cells.

Authors:  Lucia Kucerova; Miroslava Matuskova; Kristina Hlubinova; Veronika Altanerova; Cestmir Altaner
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

Review 10.  Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.

Authors:  Fatemeh Norozi; Ahmad Ahmadzadeh; Saeid Shahrabi; Tina Vosoughi; Najmaldin Saki
Journal:  Tumour Biol       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.